Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00031057 · ClinicalTrials.gov registry record · NA
Vitamin B Therapy for Hyperlactatemia
A NA study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- NA
- Development phase
- 225
- Enrollment target
NCT00031057 is a NA study that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 225 participants.
The verdict
NCT00031057, a NA study, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- NA
- Development phase
- 225 participants
- Enrollment target
Study Summary
The purpose of this study is to see if vitamin B can treat mild hyperlactatemia (a higher than normal level of lactate in the blood) in patients who take nucleoside reverse transcriptase inhibitors (NRTIs). Hyperlactatemia is a potentially life-threatening condition that can be associated with NRTI therapy. A lack of vitamin B may be related to the development of hyperlactatemia. However, no studies have been done to evaluate this. This study proposes that high doses of vitamin B may bring elevated lactate levels back to normal among patients taking NRTIs.
Interventions
- DRUG Riboflavin
- DRUG Thiamine hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00031057
The ClinicalTrials.gov registry entry for NCT00031057 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Riboflavin is the first listed.
NCT00031057 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00031057 about?
NCT00031057 is a clinical study titled "Vitamin B Therapy for Hyperlactatemia". The purpose of this study is to see if vitamin B can treat mild hyperlactatemia (a higher than normal level of lactate in the blood) in patients who take nucleoside reverse transcriptase inhibitors (NRTIs). Hyperlactatemia is a potentially life-threatening condition that can be associated with NRTI...
What is the current status of trial NCT00031057?
This trial is currently completed. It is a NA study. The enrollment target is 225 participants.
What interventions are being tested in trial NCT00031057?
The interventions under investigation include: Riboflavin (DRUG), Thiamine hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00031057?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.